His main research concerns Internal medicine, Cardiology, Atrial fibrillation, Surgery and Heart disease. His study in Internal medicine focuses on Retrospective cohort study, Implantable cardioverter-defibrillator, Catheter ablation, Stroke and Radiofrequency ablation. His research on Cardiology often connects related topics like Prospective cohort study.
His studies in Atrial fibrillation integrate themes in fields like Anesthesia and Asymptomatic. He has included themes like Quality of life and Hazard ratio in his Surgery study. His Heart disease research includes themes of Crossover study, Coronary artery disease, Defibrillation, Bradycardia and Risk factor.
His primary areas of investigation include Internal medicine, Cardiology, Atrial fibrillation, Ablation and Surgery. He connects Internal medicine with In patient in his research. His research on Cardiology often connects related areas such as Stroke.
His studies link Anesthesia with Atrial fibrillation. His Surgery study is mostly concerned with Percutaneous, Retrospective cohort study and Complication. Paul A. Friedman interconnects Cardiomyopathy and Hazard ratio in the investigation of issues within Ejection fraction.
Paul A. Friedman mostly deals with Internal medicine, Cardiology, Artificial intelligence, Electrocardiography and Atrial fibrillation. Paul A. Friedman integrates Internal medicine with In patient in his study. His Cardiology study frequently draws connections between related disciplines such as Heart rate.
His studies deal with areas such as Asymptomatic and Stenosis as well as Artificial intelligence. His biological study spans a wide range of topics, including Stroke and MEDLINE. His work deals with themes such as Population based study and Lead, which intersect with Incidence.
Paul A. Friedman mainly focuses on Internal medicine, Cardiology, Artificial intelligence, Ejection fraction and Confidence interval. Paul A. Friedman connects Internal medicine with Term in his study. His work carried out in the field of Cardiology brings together such families of science as MEDLINE and Heart rate.
His Ejection fraction study combines topics in areas such as Cluster randomised controlled trial, Randomized controlled trial, Transthoracic echocardiogram and Implant. Paul A. Friedman interconnects Electrocardiography, Left ventricular hypertrophy, Cohort and Control subjects in the investigation of issues within Confidence interval. His study focuses on the intersection of Heart failure and fields such as Atrial fibrillation with connections in the field of Ischemic stroke and Risk assessment.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation
Ravi Kanagala;Narayana S. Murali;Paul A. Friedman;Naser M. Ammash.
Circulation (2003)
Management and Outcome of Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infections
Muhammad R. Sohail;Daniel Z. Uslan;Akbar H. Khan;Paul A. Friedman.
Journal of the American College of Cardiology (2007)
Tissue capture and occlusion systems and methods
Paul A. Friedman;Charles J. Bruce;Samuel J. Asirvatham;Trevor A. Mccaw.
(2010)
Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation A 30-Year Follow-Up Study
Arshad Jahangir;Victor Lee;Paul A. Friedman;Jane M. Trusty.
Circulation (2007)
AHA/ACCF Scientific Statement on the Evaluation of Syncope: From the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation In Collaboration With the Heart Rhythm Society
S. Adam Strickberger;D. Woodrow Benson;Italo Biaggioni;David J. Callans.
Circulation (2006)
Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study.
Daniel Z. Uslan;Muhammad R. Sohail;Jennifer L. St. Sauver;Paul A. Friedman.
JAMA Internal Medicine (2007)
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19).
John R. Giudicessi;Peter A. Noseworthy;Paul A. Friedman;Michael J. Ackerman.
Mayo Clinic Proceedings (2020)
Long-Term Survival after Ablation of the Atrioventricular Node and Implantation of a Permanent Pacemaker in Patients with Atrial Fibrillation
Cevher Ozcan;Arshad Jahangir;Paul A. Friedman;Philip J. Patel.
The New England Journal of Medicine (2001)
Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker
Vivek Y. Reddy;Derek V. Exner;Daniel J. Cantillon;Rahul Doshi.
The New England Journal of Medicine (2015)
Risk Factor Analysis of Permanent Pacemaker Infection
Muhammad R. Sohail;Daniel Z. Uslan;Akbar H. Khan;Paul A. Friedman.
Clinical Infectious Diseases (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mayo Clinic
Mayo Clinic
Biotronik USA
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
Tohoku University
Technical University of Denmark
Applied Science and Technology Research Institute
Technion – Israel Institute of Technology
National Center for Atmospheric Research
University of Auckland
University of East Anglia
Max Planck Society
The University of Texas Health Science Center at San Antonio
University of Melbourne
Purdue University West Lafayette
The Ohio State University
Karolinska Institute
University of Amsterdam
University of Hong Kong
Heinrich Heine University Düsseldorf